XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies (Details) - Schedule of Consolidated Balance Sheet - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Schedule of Consolidated Balance Sheet [Abstract]    
Gross proceeds   $ 189,750,000
Less:    
Proceeds allocated to Public Warrants   (4,204,248)
Common stock issuance costs   (7,701,178)
Plus:    
Accretion of redeemable common stock $ 2,137,638 15,680,910
Contingently redeemable common stock 9,252,208 $ 193,525,484
Less:    
Partial redemption $ (186,410,914)